Krebs Biochemicals and Industries Balance Sheet
- Market cap
- ₹122 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹40.85 – ₹76.59
As of FY25, Krebs Biochemicals and Industries had total assets of ₹79.5 crore and borrowings of ₹14.68 crore, against shareholders' equity of ₹175 crore — a debt-to-equity ratio of 0.35.
Krebs Biochemicals and Industries balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 55.04 |
| Borrowings | 14.68 |
| Other liabilities | 9.78 |
| Total liabilities | 79.5 |
| Fixed assets | 42.81 |
| Capital work in progress | 45 |
| Investments | 18.35 |
| Other assets | 18.35 |
| Total assets | 79.5 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹19.91
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Krebs Biochemicals and Industries balance sheet — frequently asked questions
What is the total debt of Krebs Biochemicals and Industries?
Krebs Biochemicals and Industries reported borrowings of ₹14.68 crore as of FY25.
What is Krebs Biochemicals and Industries' debt-to-equity ratio?
Based on the FY25 balance sheet, Krebs Biochemicals and Industries' debt-to-equity ratio is 0.35 — borrowings of ₹14.68 crore against equity capital and reserves of ₹175 crore.
What are Krebs Biochemicals and Industries' total assets?
Krebs Biochemicals and Industries' total assets were ₹79.5 crore as of FY25, including fixed assets of ₹42.81 crore and investments of ₹18.35 crore.
What is the book value per share of Krebs Biochemicals and Industries?
The book value per share of Krebs Biochemicals and Industries is ₹19.91, based on the latest reported balance sheet.
Same Data For Peers
Trade Krebs Biochemicals and Industries With ATS
Track KREBSBIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.